Firms

Diamond Edge Ventures
San Francisco, California, United States
Diamond Edge Ventures, Inc. (DEV) is the corporate venture subsidiary of Mitsubishi Chemical Group, established in California in July2018 by the then-named Mitsubishi Chemical Holdings Corporation. It invests in technology companies and develops commercial and technical collaboration with group businesses. Its investment focus includes advanced manufacturing, electronic and semiconductor materials, XR displays, mobility, health and medical devices, regenerative-medicine inputs, and sustainable materials. The current public directory names President Curtis Schickner and Investment Director Naveed Ahmed, plus six explicitly affiliated commercialization-team members employed by Mitsubishi Chemical Corporation. The public15+ global team headline is broader than the eight named people and is not expanded into invented staff. DEV’s own USD200M deployment mandate through2030 is corporate investment capacity, not a third-party limited-partner fundraising close. The parent’s2021 report describes a USD150M Platform programme and USD50M Frontier programme for fiscal2021–2030; these are the components of that allocation. Former founding president Patrick Suel is recorded from historical primary publications. DEV is distinct from MP Healthcare Venture Management and from unrelated Diamond/Edge investment firms.
- Founded
- 2018
- Type
- Venture capital
Funds0
No funds on record yet.
Team
Operations and support
Co-investing
No co-investors on record yet.









